Search research articles
Contact Us
Filters
Showing results (891-900 of 903) with videos related to
Page
of 91
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2021
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
Oliver Zivanovic, Dennis S Chi, Qin Zhou, et al.
JCO Precision Oncology
|
August 11, 2020
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
Karen A Cadoo, Diana L Mandelker, Semanti Mukherjee, et al.
Cell Reports
|
November 2, 2017
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2
Aram S Modrek, Danielle Golub, Themasap Khan, et al.
Cancer Research
|
October 17, 2020
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma
Kensuke Tateishi, Yohei Miyake, Masahito Kawazu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2019
PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
Kensuke Tateishi, Taishi Nakamura, Tareq A Juratli, et al.
Nature Genetics
|
June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
Alejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.
JCO Precision Oncology
|
September 14, 2020
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent Glioblastoma
Andrew S Chi, Daniel P Cahill, David A Reardon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 8, 2018
Genotype-targeted local therapy of glioma
Ganesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
JCO Precision Oncology
|
September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer
Tiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Page
of 91
Search research articles
Search
Showing results (891-900 of 903) with videos related to
Sort By:
Page
of 91
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2021
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
Oliver Zivanovic, Dennis S Chi, Qin Zhou, et al.
JCO Precision Oncology
|
August 11, 2020
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
Karen A Cadoo, Diana L Mandelker, Semanti Mukherjee, et al.
Cell Reports
|
November 2, 2017
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2
Aram S Modrek, Danielle Golub, Themasap Khan, et al.
Cancer Research
|
October 17, 2020
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma
Kensuke Tateishi, Yohei Miyake, Masahito Kawazu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2019
PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
Kensuke Tateishi, Taishi Nakamura, Tareq A Juratli, et al.
Nature Genetics
|
June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
Alejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.
JCO Precision Oncology
|
September 14, 2020
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent Glioblastoma
Andrew S Chi, Daniel P Cahill, David A Reardon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 8, 2018
Genotype-targeted local therapy of glioma
Ganesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
JCO Precision Oncology
|
September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer
Tiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Page
of 91